|
| Attributes | Status | Number of patients/values (%) | Descriptions |
|
| HTN | Yes | 1593 (72%) | Hypertension |
| Hyperlip | Yes | 1197 (54%) | High levels of lipid (fat) in blood |
|
| DM | Yes | 602 (27%) | Diabetes |
| H/O stroke/TIA | Yes | 546 (25%) | History of stroke/TIA |
| AttrialFib | Yes | 541 (25%) | Abnormal heart rhythm |
| CAD | Yes | 513 (23%) | Coronary artery disease |
| CHF | Yes | 229 (10%) | Congestive heart failure |
| PAD/carotid Disease | Yes | 318 (14%) | Peripheral artery disease |
|
| Tobacco | Yes | 520 (23%) | Cigarette addict |
| ETOH | Yes | 308 (1.7%) | Alcohol addict |
|
| Statin | Yes | 1000 (45%) | Medications given to the patient are grouped into five broad categories |
| AntiHTN | Yes | 1332 (60%) |
| Antidiabetic | Yes | 454 (20%) |
| Antiplatelet | Yes | 1031 (47%) |
| Anticoagulation | Yes | 242 (10%) |
|
| CT perfusion | Yes | 137 (0.06%) | Procedures used for treatment |
| Neurointervention | Yes | 271 (12%) |
| mRS 90 days | Low | 2007 | Dichotomized into low (0–2), high (3–6) |
| High | 197 |
|
| Hemorrhagic con. | Yes | 204 (0.09%) | Whether the ischemic stroke turned to hemorrhagic |
|
| NIHSS admission | | 9.3 +/− 8.3 | Measures the severity of stroke |
|
| TPA | Yes | 413 (19%) | TPA (tissue plasminogen activator) is used to break down blood clots |
|
